Clinical Trial Update: Donor T Cells in Treating Patients With High-Risk Hematologic Cancer Undergoing Donor Peripheral Blood Stem Cell Transplant [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating donor T cells in high-risk hematologic cancers undergoing donor peripheral blood stem cell transplant was terminated; sponsored by th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leukemia
• Lymphoma
• Multiple Myeloma
• Myelodysplastic Syndromes
• Plasma Cell Neoplasm

Drugs mentioned

• Donor T Cells (T cells)

Snippet

Sponsor: Masonic Cancer Center, University of Minnesota | Conditions: Graft Versus Host Disease, Leukemia | Phase 1 | Status: TERMINATED